Toll Free: 1-888-928-9744

EKF Diagnostics Holdings Plc (EKF) - Product Pipeline Analysis, 2016 Update

Published: May 25, 2016 | Pages: 41 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Summary

EKF Diagnostics Holdings plc (EKF Diagnostics) is a medical device company. It designs, develops, manufactures, and commercializes chemical reagents, and analyzers for the measurement of glucose, lactate, hematocrit, hemoglobin, and glycated hemoglobin. The company's product portfolio comprises HbA1c analyzers, hemoglobin analyzers, glucose analyzers, lactate analyzers, rapid and sepsis testing kits, reagents, and biomarkers. These products find application in blood banks, general surgeries, pharmacies, hospitals, diabetes clinics, laboratories, and sports medicine. It offers these products throughout the world through subsidiaries, and distributors.  The company operates manufacturing facilities in Russia, Poland, Germany, the UK, Ireland, and the US. EKF Diagnostics is headquartered in Cardiff, Wales, the UK.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.  

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company EKF Diagnostics Holdings Plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons To Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline 
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
 Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 5 EKF Diagnostics Holdings Plc Company Snapshot 6 EKF Diagnostics Holdings Plc Company Overview 6 EKF Diagnostics Holdings Plc Pipeline Products and Clinical Trials Overview 7 EKF Diagnostics Holdings Plc - Pipeline Analysis Overview 9 Business Description 9 Key Facts 10 EKF Diagnostics Holdings Plc - Major Products and Services 11 EKF Diagnostics Holdings Plc Pipeline Products by Development Stage 13 EKF Diagnostics Holdings Plc Pipeline Products Overview 15 BIOSEN HbA1c Instrument 15 BIOSEN HbA1c Instrument Product Overview 15 Point-Of-Care Test - Coagulation 16 Point-Of-Care Test - Coagulation Product Overview 16 Point-Of-Care Test - Vitamin D Test 17 Point-Of-Care Test - Vitamin D Test Product Overview 17 PointMan AKT DNA Enrichment Kit 18 PointMan AKT DNA Enrichment Kit Product Overview 18 PointMan Assay - Breast Cancer 19 PointMan Assay - Breast Cancer Product Overview 19 PointMan Assay - Lung Cancer 20 PointMan Assay - Lung Cancer Product Overview 20 PointMan Assay - Skin Cancer 21 PointMan Assay - Skin Cancer Product Overview 21 PointMan C-Met DNA Enrichment Kit 22 PointMan C-Met DNA Enrichment Kit Product Overview 22 PointMan FGFR2 DNA Enrichment Kit 23 PointMan FGFR2 DNA Enrichment Kit Product Overview 23 PointMan FGFR4 DNA Enrichment Kit 24 PointMan FGFR4 DNA Enrichment Kit Product Overview 24 PointMan PI3K DNA Enrichment Kit 25 PointMan PI3K DNA Enrichment Kit Product Overview 25 PointMan ROS DNA Enrichment Kit 26 PointMan ROS DNA Enrichment Kit Product Overview 26 Quo-Lab - C-Reactive Protein 27 Quo-Lab - C-Reactive Protein Product Overview 27 RenaStat 28 RenaStat Product Overview 28 Xtract Liquid Phase Extraction Device 29 Xtract Liquid Phase Extraction Device Product Overview 29 EKF Diagnostics Holdings Plc - Key Competitors 30 EKF Diagnostics Holdings Plc - Key Employees 31 EKF Diagnostics Holdings Plc - Key Employee Biographies 32 EKF Diagnostics Holdings Plc - Locations And Subsidiaries 33 Head Office 33 Other Locations & Subsidiaries 33 Recent Developments 35 EKF Diagnostics Holdings Plc, Recent Developments 35 May 09, 2016: EKF Diagnostics Announces Directorate Change 35 Apr 20, 2016: EKF Diagnostics Holdings Announces Directorate Change 35 Apr 08, 2016: EKF Diagnostics Holdings Announces Directorate Change 35 Feb 02, 2016: GHS and Selah Launch a Genetic Test for Risk of Sudden Cardiac Death 36 Jan 20, 2016: EKF Diagnostics highlight new clinical chemistry analyzer at Arab Health 2016 36 Dec 01, 2015: Novel EKF biomarker identifies people likely to develop Diabetic Nephropathy 37 Oct 15, 2015: EKF's PointMan used in successful liquid biopsy research 37 Sep 28, 2015: New data published on PointMan DNA enrichment: EKF Diagnostics 38 Jul 22, 2015: New Bench-Top Clinical Chemistry Analyzer Launched By EKF Diagnostics At AACC,2015 38 Jul 16, 2015: EKF Diagnostics Growth Drives New Role Creation 39 Appendix 41 Methodology 41 About GlobalData 41 Contact Us 41 Disclaimer 41
List of Tables
EKF Diagnostics Holdings Plc Pipeline Products and Clinical Trials Overview 7 EKF Diagnostics Holdings Plc Pipeline Products by Equipment Type 7 EKF Diagnostics Holdings Plc Pipeline Products by Indication 8 EKF Diagnostics Holdings Plc, Key Facts 10 EKF Diagnostics Holdings Plc, Major Products and Services 11 EKF Diagnostics Holdings Plc Number of Pipeline Products by Development Stage 13 EKF Diagnostics Holdings Plc Pipeline Products Summary by Development Stage 14 BIOSEN HbA1c Instrument - Product Status 15 BIOSEN HbA1c Instrument - Product Description 15 Point-Of-Care Test - Coagulation - Product Status 16 Point-Of-Care Test - Coagulation - Product Description 16 Point-Of-Care Test - Vitamin D Test - Product Status 17 Point-Of-Care Test - Vitamin D Test - Product Description 17 PointMan AKT DNA Enrichment Kit - Product Status 18 PointMan AKT DNA Enrichment Kit - Product Description 18 PointMan Assay - Breast Cancer - Product Status 19 PointMan Assay - Breast Cancer - Product Description 19 PointMan Assay - Lung Cancer - Product Status 20 PointMan Assay - Lung Cancer - Product Description 20 PointMan Assay - Skin Cancer - Product Status 21 PointMan Assay - Skin Cancer - Product Description 21 PointMan C-Met DNA Enrichment Kit - Product Status 22 PointMan C-Met DNA Enrichment Kit - Product Description 22 PointMan FGFR2 DNA Enrichment Kit - Product Status 23 PointMan FGFR2 DNA Enrichment Kit - Product Description 23 PointMan FGFR4 DNA Enrichment Kit - Product Status 24 PointMan FGFR4 DNA Enrichment Kit - Product Description 24 PointMan PI3K DNA Enrichment Kit - Product Status 25 PointMan PI3K DNA Enrichment Kit - Product Description 25 PointMan ROS DNA Enrichment Kit - Product Status 26 PointMan ROS DNA Enrichment Kit - Product Description 26 Quo-Lab - C-Reactive Protein - Product Status 27 Quo-Lab - C-Reactive Protein - Product Description 27 RenaStat - Product Status 28 RenaStat - Product Description 28 Xtract Liquid Phase Extraction Device - Product Status 29 Xtract Liquid Phase Extraction Device - Product Description 29 EKF Diagnostics Holdings Plc, Key Employees 31 EKF Diagnostics Holdings Plc, Key Employee Biographies 32 EKF Diagnostics Holdings Plc, Other Locations 33 EKF Diagnostics Holdings Plc, Subsidiaries 33


List of Figures
EKF Diagnostics Holdings Plc Pipeline Products by Equipment Type 8 EKF Diagnostics Holdings Plc Pipeline Products by Development Stage 13

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global gold nanoparticles market size is expected to reach 4.99 billion by 2020, witnessing gains at a CAGR of 24.7%. Positive outlook towards the increasing applications of nanotechnology in medical and dentistry such as drug delivery systems, nanom

Read More...

Global advanced energy storage systems market size is anticipated to be valued at USD 24.8 billion by 2022, as per a new research report by Radiant Insights, Inc. Increasing energy consumption coupled with strong energy demand for industrial, commerc

Read More...

Global aquafeed market size is anticipated to be valued at USD 165.04 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in fish consumption for direct and indirect consumer applications is anticipated to drive the marke

Read More...

Global FPGA market is anticipated to be valued at USD 9,882.5 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing demand for customized IC’s is expected to drive the demand. Customized IC’s helps manufacturers to mo

Read More...

Global non destructive testing equipment market is anticipated to reach USD 5.76 billion by 2022, as per a new research report by Radiant Insights, Inc. Stringent government safety initiatives for inspection and quality control across numerous indust

Read More...
Choose License Type
Single User - US $750
Multi User - US $1500
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify